Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma

Gut

Volumn 39, Issue 3, 1996, Pages 434-438

  Cravo, M ^a   Pinto, R ^a   Fidalgo, P ^a   Chaves, P ^a   Gloria, L ^a   Nobre Leitao C ^a   Costa Mira, F ^a  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

DNA methylation; Gastric carcinogenesis; Intermediate biomarker

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA METHYLATION; FEMALE; GASTRITIS; HUMAN; INTESTINE METAPLASIA; MALE; PRIORITY JOURNAL; STOMACH CARCINOGENESIS; STOMACH CARCINOMA;

EID: 0029824194     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.39.3.434     Document Type: Article

References (53)

1. Craanen ME, Blok P, Dekker W, Ferweda J, Tytgat GNJ. Prevalence of subtypes of intestinal metaplasia in gastric antral mucosa. Dig Dis Sci 1991; 36: 1529-36.
2. Rokkas T, Filipe MI, Sladen GE. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 1991; 32: 1110-3.
3. Sipponen P, Kekki M, Siurala M. Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample. Cancer 1983; 52: 1062-8.
4. Correa P. A model for gastric cancer epidemiology. Lancet 1975; i: 58-9.
5. Correa P, Haenszel W, Cuello C, et al. Gastric precancerous process in a high risk population: cross sectional studies. Cancer Res 1990; 50: 4731-6.
6. Correa P, Haenszel W, Cuello C, et al. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res 1990; 50: 4737-40.
7. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52: 6735-40.
8. Sipponen P, Kekki M, Hapakoski J. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data, Int J Cancer 1985; 35: 173-7.
9. Sipponen P, Seppala K, Vans K, et al. Intestinal metaplasia with colonic-type sulphomucins in the gastric mucosa; its association with gastric carcinoma. Acta Pathol Microbiol Scand 1980; 88: 217-24.
10. Filipe MI, Jass JR. Intestinal metaplasia subtypes and cancer risk. In: Filipe MI, Jass JR, eds. Gastric carcinoma. Edinburgh: Churchill Livingstone, 1986: 87-115.
11. Correa P, Shiao Y. Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res 1994; 54 (suppl): 1941-3.
12. Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 1993; 119: 265-72.
13. Rhyu MG, Park WS, Jung YJ, Choi SW, Meltzer SJ. Allelic deletions of MCC/APC and p53 are frequent late events in human gastric carcinogenesis. Gastroenterology 1994; 106: 1584-8.
14. Oda N, Tsujino T, Tsuda T, Yoshida K, Nakayama H, Yasui W, Tahara E. DNA ploidy pattern and amplification of ERBB and ERBB2 genes in human gastric carcinomas. Virchows Arch B Cell Pathol 1990; 58: 273.
15. Hongyo T, Buzard GS, Palli D, Weghorst CM, Amorosi A, Galli M, et al. Mutations of the K-ras and p53 Genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Cancer Res 1994; 55: 2665-72.
16. Counts JL, Goodman JI. Alterations in DNA methylation may play a variety of roles in carcinogenesis, Cell 1995; 83: 13-5.
17. Laird PW, Jackson-Grusby L, Fazelli A, Dickinson SL, Jung WE, Li E, et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 1995; 81: 197-205.
18. Fergusson AT, Lapidus RG, Baylin SB, Davidson NE. Cancer Res 1995; 55: 2279-83.
19. Gama-Sosa MA, Slagel VA, de Bustros A, Trewin RW, Oxenhandler R, Kuo, et al. The 5-methylcytosine content of DNA from human tumors. Nucleic Acid Res 1983; 11: 6883-94.
20. Cravo M, Fidalgo P, Pereira AD, Gouveia-Oliveira A, Chaves, et al. DNA methylation as an intermediate biomarker in colorectal cancer: modulation by folic acid. Eur J Cancer Prev 1994; 3: 473-9.
21. Feinberg AP, Gerrke CW, Kuo KC, Ehrlich M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 1988; 48: 1159-61.
22. Goelz SE, Vogelstein B. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 1985; 228: 187-90.
23. Feinberg AP, Vogelstein B. Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Commun 1983; 111: 47-54.
24. Kim YI, Giuliano A, Hatch K, Schneider A, Nour MA, et al. Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma. Cancer 1994; 74: 893-9.
25. Sharrard RM, Royds JA, Rogers S, Shorthouse AJ. Patterns of methylation of the c-myc gene in human colorectal cancer progression. Br J Cancer 1992; 65: 667-72.
26. Silverman AL, Park J-G, Hamilton SR, Gazdar AF, Luk GD, Baylin SB. Abnormal methylation of the carcitonin gene in human colonic neoplasms. Cancer Res 1989; 49: 3468-73.
27. de Bustros A, Nelkin BD, Silverman A, Ehrlich G, Poiesz B, Baylin SB. The short arm of chromosome 11 is a "hotspot" for hypermethylation in human neoplasia. Proc Natl Acad J Sci USA 1988; 85: 5693-7.
28. Baylin SB, Makos M, Wu J, Yen R-CW, de Bustros A, Vertino P, et al. Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells 1992; 3: 383-90.
29. Doerfler W, Toth M, Kochanek S, Achten S, Freisem-Rabien U, Behn-Krappa A, et al. Eukaryotic DNA methylation: facts and problems. FEBS Lett 1990; 268: 329-33.
30. Razin A, Cedar H. DNA methylation and gene expression. Microbil Res 1991; 55: 451-8.
31. Bird A. The essentials of DNA methylation. Cell 1992; 70: 5-8.
32. Cedar H. DNA methylation and gene activity. Cell 1988; 53: 3-4.
33. Razin A, Szyf M. DNA methylation patterns. Formation and function. Biochem Biophys Acta 1984; 782: 331-42.
34. Correa P. The epidemiology and pathogenesis of chronic gastritis. Three etiologic entities. Front Gastroenterol Res 1980; 6: 98-108.
35. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965; 64: 31-49.
36. Spiessl B, Beahrs OH, Hermanek P, Hutter RVP, Scheibe O, Sobin LH, et al. TNM atlas. UICC. 3rd ed. Berlin: Springer Verlag, 1992.
37. Filipe MI, Lake BD. Histochemistry in pathology. Edinburgh: Churchill Livingstone, 1983.
38. Johns MB, Paulus-Thomas JE. Purification of human genomic DNA from whole blood using sodium perchlorate in place of phenol. Anal Biochem 1989; 180: 276-8.
39. Balaghi M, Wagner C. DNA methylation in folate deficiency. Biochem Biophys Res Commun 1993; 193: 1184-90
40. Imai T, Maryama H. Time trend in the prevalence of intestinal metaplasia. Cancer 1983; 52: 173-7.
41. Stemmermann GN, Hayashi T. Intestinal metaplasia of the gastric mucosa: a gross and microscopic study of its distribution in various disease states. J Natl Cancer Inst 1968; 41: 627-34.
42. Meister H, Holubarsch CH, Haferkamp O, Schlag P. Gastritis, intestinal metaplasia and dysplasia versus benign ulcer in stomach and duodenum and gastric carcinoma: a histotopographic study. Pathol Res Pract 1979; 164: 256-69.
43. Miller JW, Nadeau MR, Smith J, Smith D. Selhub J. Folate deficiency-induced homocysteinemia in rats: disruption of S-adenosylmethionine's coordinate regulation of homocysteine metabolism. Biohcem J 1994; 298: 415-9.
44. Balaghi M, Home DW, Wagner C. Hepatic one-carbon metabolism in early folate deficiency in rats. Biochem J 1993; 191: 145-9.
45. M Cravo ML, Mason JB, Dayal Y, Hutchinson M, Smith D, Selhub J, Rosenberg IH. Eolate deficiency enhances the development of colonic neoplasia in dimethyl-hydrazine-treated rats. Cancer Res 1992; 52: 5002-6.
46. Butterworth CE, Hatch KD, Macaluso M, Cole P, Sauerlich HE, Soog SJ, et al. Folate deficiency and cervical dysplasia. JAMA 1992; 267: 528-33.
47. Heimburger DC, Alexander CB, Birch R, Butterworth CE Jr, Bailey WC, Krumdieck CL. Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. JAMA 1988; 259: 1525-30.
48. Demirer T, Icli F, Uzunalimoglu, Kucuk O. Diet and stomach cancer incidence. Cancer 1990; 65: 2344-8.
49. Ramon JM, Serra L, Cerdo C, Oromi J. Dietary factors and gastric cancer risk. Cancer 1993; 71: 17315.
50. Chyou PH, Nomura AMY, Hankin JH, Stemmermann. A case-cohort study of diet and stomach cancer. Cancer Res 1990; 50: 7501-4.
51. National Cancer Institute. Annual cancer statistics review: 1973-1991. Bethesda, MD: Department of Health and Human Services, 1994. (DHHS publ No 27 NIH 94-2789).
52. Euchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995; 333: 32-11.
53. Kaibara N, Kawagushi H, Nishidoi H, Kimura O, Okamoto T, Koga S, Fukumoto S. Significance of mass survey for gastric cancer from the standpoint of surgery. Am J Surg 1981; 142: 543-5.